通过向线粒体亡来增强基于NK细胞的免疫疗法
Rongqing Pan1, Jeremy Ryan1, Deng Pan2
1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Cell
|April 21, 2022
概括
自然杀手细胞对于癌症免疫疗法至关重要,但它们的有效性有限. 这项研究表明,增强癌细胞中的线粒体亡途径可以提高NK细胞的杀死效率,从而提供一种新的治疗策略.
科学领域:
- 免疫学
- 癌症生物学
- 细胞死亡途径
背景情况:
- 基于自然杀手细胞 (NK) 的免疫疗法对癌症治疗具有前景,但临床疗效受到限制.
- 增加NK细胞的细胞毒性对于改善免疫治疗结果至关重要.
- 线粒体亡 (mtApoptosis) 途径在NK细胞中介细胞毒性的作用需要进一步阐明.
研究的目的:
- 调查mtApoptosis途径在NK细胞介导的癌细胞杀死中的重要作用.
- 探索NK细胞如何为mtApoptosis培养癌细胞,以及这如何影响敏感性.
- 为增强基于NK细胞的癌症免疫疗法制定合理的策略.
主要方法:
- 研究了mtaapoptosis途径对NK细胞毒性的必要性.
- 评估NK细胞对癌细胞进行mtaapoptosis的能力.
- 使用BH3分析来预测组合治疗的最佳BH3模拟剂.
- 在实验室和体内评估了与NK细胞结合BH3模拟剂的协同效应.
主要成果:
- 对于有效的NK细胞杀死,mtApoptosis途径是必不可少的,特别是在生理效应器与点的比率上.
- NK细胞可以诱导癌细胞中的线粒体初始化,从而影响它们对NK介导杀死的易感性.
- 预激活的NK细胞对BH3模拟剂呈现耐药性.
- 结合BH3模拟剂与NK细胞,可以在体外显示出协同作用的癌细胞杀死和体内抑制瘤生长.
结论:
- 在癌症免疫治疗中,mtApoptosis途径是NK细胞疗效的关键决定因素.
- 针对线粒体原始化和将BH3模拟剂与NK细胞结合,为增强癌症免疫疗法提供了有效的策略.
- 这种以BH3分析为指导的精确方法可以改善NK细胞治疗方法,并可能适用于基于T细胞的免疫疗法.
相关概念视频
Tumor Immunotherapy
689
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
689
Electron Transport Chain: Complex I and II
15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Cytotoxic T Cells-mediated Immune Response
2.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.8K
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K


